EichorEICHOR
Location: Belgrade Synced from ClinicalTrials.gov · August 09, 2026

Clinical studies recruiting near Belgrade

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients Wit
Phase 1 · University Clinical Center of Serbia · eleva GmbH · NCT07483827A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Phase 2 · Clinical Hospital Center Zvezdara · Boehringer Ingelheim · NCT06636656Continuos Body Temperature Monitoring
Phase N/A · University Clinical Center of Serbia, Clinic for Infectious · Baby FM Doo · NCT06447337A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Phase 3 · Childrens University Hospital · H. Lundbeck A/S · NCT05897320First-In-Human Clinical Study for Treatment of Severe Mitral Valve INsufficiency With Epygon™ TRanscatheter Mitral VAlve
NA · Dedinje Cardiovascular Institute · Epygon · NCT04775108Randomization of Single vs Multiple Arterial Grafts
NA · Dedinje Cardiovascular Institute · Weill Medical College of Cornell University · NCT03217006Bone Substitutes and NIPSA in Intrabony Periodontal Defects: A Randomized Controlled Trial
NA · Department of Periodontology and Research Implant Center, Sc · University of Belgrade · NCT07671963LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · MSB General Hospital · Eli Lilly and Company · NCT07415044A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Phase 3 · Clinical Center of Serbia · argenx · NCT06544499The C-MIC-II Follow-Up Study
NA · Clinical Center of Serbia · Berlin Heals GmbH · NCT05189860Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery
Phase 3 · Clinical Center of Serbia · Octapharma · NCT04918173PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS
Phase 2 · University Clinical Center of Serbia · PhenoNet, Inc. · NCT07142291A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Phase 3 · University Clinical Center of Serbia - Dr Subotica 6 - PPDS · Longboard Pharmaceuticals · NCT06660394Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Phase 2 · Clinic for Neurology and Psychiatry for Children and Youth · Amgen · NCT05549258DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refrac
Phase 2 · University Clinical Center of Serbia · ImmunoVaccine Technologies, Inc. (IMV Inc.) · NCT04920617Exploratory Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma
Phase N/A · KBC Bežanijska kosa · University of Belgrade · NCT07378709A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate
Phase 3 · Teva Investigational Site 61089 · Teva Branded Pharmaceutical Products R&D LLC · NCT06664619A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection
Phase 2 · TG Therapeutics Investigational Trial Site · TG Therapeutics, Inc. · NCT07503873A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)
Phase 1/Phase 2 · Climb Bio Investigative Site #381201 · Climb Bio, Inc. · NCT07043946Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
Phase 2 · University Clinical Center of Serbia, Neurology Clinic · NMD Pharma A/S · NCT06414954A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), a
Phase 2 · Clinical Hospital Center 'Dr Dragisa Misovic - Dedinje' · Actimed Therapeutics Ltd · NCT07101939Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
Phase 2 · Clinical Site 2 · Intra-Cellular Therapies, Inc. · NCT06480383Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophreni
Phase 3 · Clinic.Neuro.Psych.Child.Youth · Gedeon Richter Plc. · NCT03817502A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared t
Phase 2 · Research Site · AstraZeneca · NCT07525375Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Phase 2 · Clinical Site_2 · Intra-Cellular Therapies, Inc. · NCT06701903Volrustomig Priming Regimens Exploratory Phase II Platform Study
Phase 2 · Research Site · AstraZeneca · NCT06448754A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
Phase 3 · Clinical Centre of Serbia, Institute for Haematology · Novo Nordisk A/S · NCT05685238Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
NA · University of Belgrade, Faculty of Pharmacy · Parnassia Groep · NCT05656469An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combinati
Phase 2 · University Clinical Center Serbia /ID# 277007 · AbbVie · NCT07155174
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.